Open AccessPD-1 receptor blocker
Author(s) -
Muhammad Faraz Shamshad,
Sajid Ali Khan,
Disha Mitra,
Samiksha Gupta,
Shaikh Rajesh Ali,
Nadeem Siddiqui,
Supriyo Mukherjee
Publication year - 2022
Publication title -
international journal of health sciences (ijhs) (en línea)
Language(s) - Uncategorized
Resource type - Journals
eISSN - 2550-6978
pISSN - 2550-696X
DOI - 10.53730/ijhs.v6ns8.12824
Subject(s) - avelumab , pembrolizumab , nivolumab , durvalumab , ipilimumab , medicine , immune checkpoint , cancer , monoclonal antibody , immune system , oncology , antibody , cancer research , immunotherapy , immunology